Advertisement

Topics

Acceleron Provides Updated Results from Ongoing Phase 2 Study of Luspatercept in ...

22:06 EDT 22 Jun 2017 | BioMedReports - Blog

- Results from ongoing trials demonstrate increases in hemoglobin and reductions in red blood cell transfusion burden sustained for more than 26 months -

Read more...

Original Article: Acceleron Provides Updated Results from Ongoing Phase 2 Study of Luspatercept in ...

NEXT ARTICLE

More From BioPortfolio on "Acceleron Provides Updated Results from Ongoing Phase 2 Study of Luspatercept in ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...